These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 29736241)
1. Pseudomonas pharyngitis in a cystic fibrosis patient. Pradeepan S; Wark P Respirol Case Rep; 2018 Jul; 6(5):e00325. PubMed ID: 29736241 [TBL] [Abstract][Full Text] [Related]
2. Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis. Chandler CE; Hofstaedter CE; Hazen TH; Rasko DA; Ernst RK Microbiol Spectr; 2023 Aug; 11(4):e0155623. PubMed ID: 37358436 [TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis. Avendaño-Ortiz J; Llanos-González E; Toledano V; Del Campo R; Cubillos-Zapata C; Lozano-Rodríguez R; Ismail A; Prados C; Gómez-Campelo P; Aguirre LA; García-Río F; López-Collazo E J Cyst Fibros; 2019 Sep; 18(5):630-635. PubMed ID: 30442491 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for cystic fibrosis arthropathy: Data from the German cystic fibrosis registry. Grehn C; Dittrich AM; Wosniok J; Holz F; Hafkemeyer S; Naehrlich L; Schwarz C; J Cyst Fibros; 2021 Nov; 20(6):e87-e92. PubMed ID: 34034985 [TBL] [Abstract][Full Text] [Related]
5. Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection. Moore R; Kyd JM; Carzino R; Armstrong D; Grimwood K; Otczyk DC; Cripps AW Hum Vaccin Immunother; 2013 Mar; 9(3):506-14. PubMed ID: 23249482 [TBL] [Abstract][Full Text] [Related]
6. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700 [TBL] [Abstract][Full Text] [Related]
7. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. Tablan OC; Chorba TL; Schidlow DV; White JW; Hardy KA; Gilligan PH; Morgan WM; Carson LA; Martone WJ; Jason JM J Pediatr; 1985 Sep; 107(3):382-7. PubMed ID: 4032134 [TBL] [Abstract][Full Text] [Related]
8. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT. Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975 [TBL] [Abstract][Full Text] [Related]
9. The burden of sinus disease in cystic fibrosis lung transplant recipients. Morlacchi LC; Greer M; Tudorache I; Blasi F; Welte T; Haverich A; Mainz JG; Gottlieb J Transpl Infect Dis; 2018 Oct; 20(5):e12924. PubMed ID: 29797646 [TBL] [Abstract][Full Text] [Related]
10. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772 [TBL] [Abstract][Full Text] [Related]
11. Highly diverse dynamics of Pseudomonas aeruginosa colonization from initial detection in cystic fibrosis patients: A 7-year longitudinal genetic diversity study. Dupont C; Aujoulat F; Benaoudia M; Jumas-Bilak E; Chiron R; Marchandin H Infect Genet Evol; 2023 Nov; 115():105513. PubMed ID: 37832753 [TBL] [Abstract][Full Text] [Related]
12. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa. Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB mBio; 2020 Jun; 11(3):. PubMed ID: 32576671 [No Abstract] [Full Text] [Related]
13. The Microbiology of Non- Moore JE; McCaughan J; Rendall JC; Millar BC Br J Biomed Sci; 2022; 79():10468. PubMed ID: 35951661 [No Abstract] [Full Text] [Related]
14. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Tablan OC; Martone WJ; Doershuk CF; Stern RC; Thomassen MJ; Klinger JD; White JW; Carson LA; Jarvis WR Chest; 1987 Apr; 91(4):527-32. PubMed ID: 3829745 [TBL] [Abstract][Full Text] [Related]
15. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report. Walicka-Serzysko K; Sands D Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072 [TBL] [Abstract][Full Text] [Related]
16. The effect of Pseudomonas aeruginosa eradication regimens on chronic colonization and clinical outcomes in pediatric patients with cystic fibrosis. Nayir Buyuksahin H; Yalçın E; Emiralioglu N; Hazırolan G; Ademhan Tural D; Ozsezen B; Sunman B; Guzelkas I; Dogru D; Ozcelik U; Kiper N Pediatr Int; 2022 Jan; 64(1):e15249. PubMed ID: 36321341 [TBL] [Abstract][Full Text] [Related]